Statin Use and Reduced Risk of Sudden Sensorineural Hearing Loss in Type 2 Diabetes
Statin use in T2D patients is associated with reduced SSNHL risk and all-cause mortality, with dose-dependent effects. These findings suggest the potential otoprotective benefits of statins and emphasize the importance of personalized therapy for managing both hearing and cardiovascular health in this high-risk population.
Authors
- Szu‐Yuan Wu (ORCID: https://orcid.org/0000-0001-5637-558X)
- Ben‐Chang Shia (ORCID: https://orcid.org/0000-0003-2854-8361)
- Jr‐Shiang Shiu
- Tongyun Li
- Wan‐Ming Chen (ORCID: https://orcid.org/0009-0009-6628-0635)
- Lin He (ORCID: https://orcid.org/0000-0003-1079-1195)
Institutions
- Fu Jen Catholic University (TW)
- Asia University (TW)
- Luodong Poh-Ai Hospital (TW)
- Ministry of Health and Welfare (TW)
Publication Details
- Journal
- Otolaryngology
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1002/ohn.1214
- Citations
- 2
- Primary Topic
- Vestibular and auditory disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.68